Zeng, J., Loi, G. W. Z., Saipuljumria, E. N., Duránc, M. A. R., Silva-García, O., Perez-Aguilard, J. M., . . . (LKCMedicine), L. K. C. S. o. M. (2024). Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex.

Zeng, Jialiu, Gavin Wen Zhao Loi, Eka Norfaishanty Saipuljumria, Marco Antonio Romero Duránc, Octavio Silva-García, Jose Manuel Perez-Aguilard, Víctor M. Baizabal-Aguirre, Chih Hung Lo, and Lee Kong Chian School of Medicine (LKCMedicine). Peptide-based Allosteric Inhibitor Targets TNFR1 Conformationally Active Region and Disables Receptor-ligand Signaling Complex. 2024.

Zeng, Jialiu, et al. Peptide-based Allosteric Inhibitor Targets TNFR1 Conformationally Active Region and Disables Receptor-ligand Signaling Complex. 2024.